Overview

Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiation

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate time to progression (TTP) by PSA in patients with high risk prostate cancer after definitive therapy.
Phase:
Phase 2
Details
Lead Sponsor:
Stanford University
Collaborator:
Aventis Pharmaceuticals
Treatments:
Docetaxel